Literature DB >> 19567825

Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment.

Linda P Fried1, Qian-Li Xue, Anne R Cappola, Luigi Ferrucci, Paulo Chaves, Ravi Varadhan, Jack M Guralnik, Sean X Leng, Richard D Semba, Jeremy D Walston, Caroline S Blaum, Karen Bandeen-Roche.   

Abstract

BACKGROUND: Frailty in older adults, defined as a constellation of signs and symptoms, is associated with abnormal levels in individual physiological systems. We tested the hypothesis that it is the critical mass of physiological systems abnormal that is associated with frailty, over and above the status of each individual system, and that the relationship is nonlinear.
METHODS: Using data on women aged 70-79 years from the Women's Health and Aging Studies I and II, multiple analytic approaches assessed the cross-sectional association of frailty with eight physiological measures.
RESULTS: Abnormality in each system (anemia, inflammation, insulin-like growth factor-1, dehydroepiandrosterone-sulfate, hemoglobin A1c, micronutrients, adiposity, and fine motor speed) was significantly associated with frailty status. However, adjusting for the level of each system measure, the mean number of systems impaired significantly and nonlinearly predicted frailty. Those with three or more systems impaired were most likely to be frail, with odds of frailty increasing with number of systems at abnormal level, from odds ratios (ORs) of 4.8 to 11 to 26 for those with one to two, three to four, and five or more systems abnormal (p < .05 for all). Finally, two subgroups were identified, one with isolated or no systems abnormal and a second (in 30%) with multiple systems abnormal. The latter group was independently associated with being frail (OR = 2.6, p < .05), adjusting for confounders and chronic diseases and then controlling for individual systems.
CONCLUSIONS: Overall, these findings indicate that the likelihood of frailty increases nonlinearly in relationship to the number of physiological systems abnormal, and the number of abnormal systems is more predictive than the individual abnormal system. These findings support theories that aggregate loss of complexity, with aging, in physiological systems is an important cause of frailty. Implications are that a threshold loss of complexity, as indicated by number of systems abnormal, may undermine homeostatic adaptive capacity, leading to the development of frailty and its associated risk for subsequent adverse outcomes. It further suggests that replacement of any one deficient system may not be sufficient to prevent or ameliorate frailty.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567825      PMCID: PMC2737590          DOI: 10.1093/gerona/glp076

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  33 in total

Review 1.  A conceptual framework of frailty: a review.

Authors:  Walter M Bortz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-05       Impact factor: 6.053

Review 2.  Reverse engineering of biological complexity.

Authors:  Marie E Csete; John C Doyle
Journal:  Science       Date:  2002-03-01       Impact factor: 47.728

Review 3.  Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging.

Authors:  Bruce S McEwen
Journal:  Metabolism       Date:  2003-10       Impact factor: 8.694

Review 4.  The reliability-engineering approach to the problem of biological aging.

Authors:  Leonid A Gavrilov; Natalia S Gavrilova
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

Review 5.  Physiological complexity, aging, and the path to frailty.

Authors:  Lewis A Lipsitz
Journal:  Sci Aging Knowledge Environ       Date:  2004-04-21

6.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.

Authors:  Jeremy Walston; Mary Ann McBurnie; Anne Newman; Russell P Tracy; Willem J Kop; Calvin H Hirsch; John Gottdiener; Linda P Fried
Journal:  Arch Intern Med       Date:  2002-11-11

7.  Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels.

Authors:  Luigi Ferrucci; Brenda W J H Penninx; Stefano Volpato; Tamara B Harris; Karen Bandeen-Roche; Jennifer Balfour; Suzanne G Leveille; Linda P Fried; Jack M Guralnik Md
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

8.  Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women.

Authors:  Anne R Cappola; Qian-Li Xue; Luigi Ferrucci; Jack M Guralnik; Stefano Volpato; Linda P Fried
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

9.  Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty.

Authors:  Sean X Leng; Anne R Cappola; Ross E Andersen; Marc R Blackman; Kathleen Koenig; Michael Blair; Jeremy D Walston
Journal:  Aging Clin Exp Res       Date:  2004-04       Impact factor: 3.636

10.  The estimation of relative fitness and frailty in community-dwelling older adults using self-report data.

Authors:  Arnold B Mitnitski; Xiaowei Song; Kenneth Rockwood
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-06       Impact factor: 6.053

View more
  197 in total

Review 1.  Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making.

Authors:  Gretchen Kimmick
Journal:  Curr Treat Options Oncol       Date:  2011-09

2.  Proteomic screening of glycoproteins in human plasma for frailty biomarkers.

Authors:  Kinza S Shamsi; Anson Pierce; Aaron S Ashton; Dipti G Halade; Arlan Richardson; Sara E Espinoza
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-01-04       Impact factor: 6.053

3.  A prospective study of frailty in nephrology-referred patients with CKD.

Authors:  Baback Roshanravan; Minesh Khatri; Cassianne Robinson-Cohen; Greg Levin; Kushang V Patel; Ian H de Boer; Stephen Seliger; John Ruzinski; Jonathan Himmelfarb; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2012-07-07       Impact factor: 8.860

4.  Can routine preoperative data predict adverse outcomes in the elderly? Development and validation of a simple risk model incorporating a chart-derived frailty score.

Authors:  Levana G Amrock; Mark D Neuman; Hung-Mo Lin; Stacie Deiner
Journal:  J Am Coll Surg       Date:  2014-06-03       Impact factor: 6.113

5.  Physiological Dysregulation, Frailty, and Risk of Mortality Among Older Adults.

Authors:  Jennifer C Cornman; Dana A Glei; Noreen Goldman; Maxine Weinstein
Journal:  Res Aging       Date:  2016-02-09

6.  Adequate dietary protein is associated with better physical performance among post-menopausal women 60-90 years.

Authors:  L Gregorio; J Brindisi; A Kleppinger; R Sullivan; K M Mangano; J D Bihuniak; A M Kenny; J E Kerstetter; K L Insogna
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

Review 7.  The Relationship between Anaemia and Frailty: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  K Palmer; D L Vetrano; A Marengoni; A M Tummolo; E R Villani; N Acampora; R Bernabei; G Onder
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 8.  Comparative Approaches to Understanding the Relation Between Aging and Physical Function.

Authors:  Jamie N Justice; Matteo Cesari; Douglas R Seals; Carol A Shively; Christy S Carter
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-04-23       Impact factor: 6.053

9.  Prevalence and outcomes of fragility: a frailty-inflammation phenotype in children with chronic kidney disease.

Authors:  Kristen Sgambat; Matthew B Matheson; Stephen R Hooper; Bradley Warady; Susan Furth; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2019-08-02       Impact factor: 3.714

10.  Multi-morbidity, dependency, and frailty singly or in combination have different impact on health outcomes.

Authors:  Jean Woo; Jason Leung
Journal:  Age (Dordr)       Date:  2013-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.